Overview of Core
The Core has assays for GTPgS and CB1 cannabinoid receptors and is working on the development of assays for mu, delta and kappa opioid receptors. Also in development are assays for CB2, and OFQ receptors and Ca2+ signaling. Additional receptor, ion channel, and transporter binding assays are in the planning stage.
|